33 min
Exploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter The ConcertAI Podcast
-
- Life Sciences
A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model.
In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical Trial (DACT) model in the biopharma industry which leverages automation and integrates with various clinical data sources to collect more data and improve trial efficiency. This not only allows for more rapid completion of trials, but also facilitates the identification of eligible patients.
Join us as we explore these exciting developments and learn how they are changing the biopharma landscape.
Website
www.ConcertAI.com
LinkedIn
www.linkedin.com/company/concertai/
Twitter
www.twitter.com/concertai
A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model.
In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical Trial (DACT) model in the biopharma industry which leverages automation and integrates with various clinical data sources to collect more data and improve trial efficiency. This not only allows for more rapid completion of trials, but also facilitates the identification of eligible patients.
Join us as we explore these exciting developments and learn how they are changing the biopharma landscape.
Website
www.ConcertAI.com
LinkedIn
www.linkedin.com/company/concertai/
Twitter
www.twitter.com/concertai
33 min